Needham Maintains Buy on Immunocore Holdings, Raises Price Target to $75
Benzinga Newsdesk 8 months ago
NewsPrice TargetAnalyst Ratings
Needham analyst Gil Blum maintains Immunocore Holdings (NASDAQ:IMCR) with a Buy and raises the price target from $71 to $75.
Needham analyst Gil Blum maintains Immunocore Holdings (NASDAQ:IMCR) with a Buy and raises the price target from $71 to $75.